ODOB > Events > Glaucoma 1: Pharmacology

Glaucoma 1: Pharmacology

Date: Thu 01/11/2018 - Sat 31/10/2020

Provider: Luxottica Institute of Learning

Optometrist Credits: 1 Clinical Diagnostic Credit

Event Type(s): Online

Contact


Few areas in eye heath are changing as fast as glaucoma treatment and management. For optometrists there are a variety of options available to treat your patients’ glaucoma starting with eye drops and progressing to laser procedures and surgery. With a number of options available to treat glaucoma there is more to glaucoma than raised intraocular pressure.

LEARNING OUTCOMES

  1. Understand the indications, contraindications, dosing, and adverse effects associated with prostaglandin analogues.

  2. Understand how the sympathetic and parasympathetic nervous system is used to develop medications to treat glaucoma.

  3. Understand the indications, contraindications, dosing, and adverse effects associated with cholinergic agonists, alpha adrenergic agonists, beta-blockers, carbonic anhydrase inhibitors and RhoKinase inhibitors.

  4. Understand the role of nitric oxide and nitric oxide-donating prostaglandin analogues in reducing intraocular pressure.

  5. Understand the novel actions of RhoKinase inhibitors in reducing intraocular pressure.

  6. Understand the true contraindications for beta-blockers and discern which adverse effects are not due to

    beta blockade.

Despite all of the new knowledge in glaucoma pathophysiology and all of the new therapies under study, our only therapeutic option currently available is intraocular pressure (IOP) reduction. While laser trabeculoplasty and incisional ocular surgery always remain options, medical therapy is typically employed first. Safety and efficacy are chief among the reasons that medications are the mainstay of glaucoma therapy. This module addresses the medications available to manage patients with glaucoma.

Log this activity to my CPD

Location

This event does not have a physical location